Clinical Trial Update: A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, and blood levels of multiple doses of PF-044467943 (with donepezil) in mild to moderate Alzheimer's disease compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil (donepezil)
• PF-044467943 (PF-044467943)

Snippet

Sponsor: Pfizer | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED | Results posted: 2020-11-19